Phoenix Ancient Art Clarifies Misleading Article Regarding Ali Aboutaam from Thomson Reuters
Posted on: Wednesday, 28 January 2009, 04:00 CST
The story stated that Mr. Aboutaam was under arrest in
A registered letter was sent on
As a result, Thomson Reuters published the same day, a new dispatch specifying the facts underlying its initial news report and indicating this time that the Sofia High court,
To summarize the background: Mr. Aboutaam was sentenced in absentia to 15 years imprisonment in
The Egyptian nationals who were the subject of this trial appealed the judgment pronounced against them. The verdict of the trial court judges was thus overturned. Eventually, on
It should be noted that following the proceedings, the three principal accused were fully and finally exonerated from the accusations of smuggling antiquities by the Egyptian judges, thereby exonerating any individual accused of aiding and abetting. This final definitive judgment nullifies the idea put forth by the Egyptian judicial authorities that Mr. Aboutaam would be entitled to a new trial if he returned to
It was also noted in the terms of the statements issued by the Egyptian Ministry of Culture that a link had been established between the seizure of Egyptian antiquities (280-300 artifacts) in
It is consequently both shocking and intolerable that the Egyptian Ministry of Culture has been authorized, without the slightest verification by the Thomson Reuters agency, to issue such statements, which have no basis and are contrary to the actual facts. In the interim, those facts have been confirmed by the Bulgarian judicial authorities. The remarks made by the Egyptian Ministry of Culture, and more particularly Mr.
Phoenix Ancient Art continues to pride itself on its transparency and dedication to complying with and working with law enforcement to ensure the integrity of the legal antiquities trade in all nations.
SOURCE Phoenix Ancient Art
Source: PR Newswire
Related Articles
- Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials
- Thomson Reuters Releases 2008 Journal Citation Reports
- Thomson Reuters White Paper Explores the Role of Biomarkers in Clinical Trials and Drug Development
- Thomson Reuters Releases ISI Web of Knowledge and EndNote Web in Chinese
- The Scientific Business of Thomson Reuters Predicts Nobel Laureates
- Thomson Reuters to Provide Online Cancer Treatment Decision Support Tools for Tigerlily Foundation
- Thomson Reuters Adds Citation Mapping Tool to ISI Web of Knowledge
- Researchers Tapped Thomson Reuters Community of Cancer Patients for Studies To Be Reported at American Society of Clinical Oncology Conference
- Thomson Reuters and Lance Armstrong Foundation Provide Online Cancer Information
User Comments (0)

RSS Feeds